The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Janssen Sciences Ireland UC .

Filed returns
9
match these filters
Matching filed returns per period 0 1 2 3 5 Sep–Dec 2023: 1 filed returns Jan–Apr 2024: 1 filed returns May–Aug 2024: 2 filed returns Sep–Dec 2025: 1 filed returns Jan–Apr 2026: 3 filed returns May–Aug 2026: 1 filed returns 2024 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Janssen Sciences Ireland UC EU Affairs Meeting with J&J Senior Leadership in Cork to discuss upcoming Irish Presidency of the EU and competitiveness (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2026 Janssen Sciences Ireland UC EU Affairs Meeting to discuss EU Presidency Plans (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2026 Janssen Sciences Ireland UC EU Affairs Meeting with Irish Perm Rep on Critical Medicines policy (Legislation) 1 On lobbying.ie
Jan–Apr 2026 Janssen Sciences Ireland UC EU Affairs Engagements in relation to Biotech Act I (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2025 Janssen Sciences Ireland UC EU Affairs Meeting with Maeve von Heynitz (Public policy or programme) 1 On lobbying.ie
May–Aug 2024 Janssen Sciences Ireland UC EU Affairs Engagement with the Taoiseach on the review of the EU general pharmaceutical legislation. (Legislation) 1 On lobbying.ie
May–Aug 2024 Janssen Sciences Ireland UC EU Affairs Engagement with MEP candidate on revision of the EU general pharmaceutical legislation. (Legislation) 1 On lobbying.ie
Jan–Apr 2024 Janssen Sciences Ireland UC EU Affairs Engagement with Irish MEPs on EU pharmaceutical policy. (Public policy or programme) 4 On lobbying.ie
Sep–Dec 2023 Janssen Sciences Ireland UC EU Affairs Engagement on the EU revision of pharmaceutical legislation (Legislation) 1 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
EU Affairs 9 100.0%